Invasive Candidiasis in Liver Transplant Recipients: A Review

Purpose of Review This review summarizes the literature on invasive candidiasis (IC) in liver transplant recipients (LTRs) regarding diagnostic strategies, treatment, and prophylaxis. Recent Findings Recent literature on IC has expanded and refined definitions of risk factors for IC in LTRs. We disc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current fungal infection reports 2021-12, Vol.15 (4), p.151-161
Hauptverfasser: Sigler, Rachel, Aslam, Saima
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 161
container_issue 4
container_start_page 151
container_title Current fungal infection reports
container_volume 15
creator Sigler, Rachel
Aslam, Saima
description Purpose of Review This review summarizes the literature on invasive candidiasis (IC) in liver transplant recipients (LTRs) regarding diagnostic strategies, treatment, and prophylaxis. Recent Findings Recent literature on IC has expanded and refined definitions of risk factors for IC in LTRs. We discuss increasing rates of resistance among candida species and new antifungals. Diagnostic modalities continue to decrease time to initiation of empiric antifungals, which may impact outcomes. Summary A well-documented host of risk factors for IC may allow for targeted prophylaxis, while minimizing exposure to antifungal medications. Further research on minimum effective duration of treatment and prophylaxis is needed to combat resistance.
doi_str_mv 10.1007/s12281-021-00426-6
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2604853565</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2604853565</sourcerecordid><originalsourceid>FETCH-LOGICAL-c270t-65d7b965de7719c2ef9e6b9c16e6404f35c77af2ee1971a601e71448b455a1923</originalsourceid><addsrcrecordid>eNp9UE1LAzEUDKJgrf4BTwueV_Py2QgeSrFaKAhSwVvI7r6VlJquybbivze6ojcP72MeM_NgCDkHegmU6qsEjE2gpCwXFUyV6oCMwHBVcq2fD393BcfkJKU1pQq04SNyswh7l_wei5kLjW98BqnwoVjmWyxW0YXUbVzoi0esfecx9Om6mGa09_h-So5at0l49jPH5Gl-u5rdl8uHu8VsuixrpmlfKtnoyuSOWoOpGbYGVWVqUKgEFS2XtdauZYhgNDhFATUIMamElA4M42NyMfh2cfu2w9Tb9XYXQ35pmaJiIrlUMrPYwKrjNqWIre2if3XxwwK1XzHZISabY7LfMVmVRXwQpUwOLxj_rP9RfQLCmmkC</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2604853565</pqid></control><display><type>article</type><title>Invasive Candidiasis in Liver Transplant Recipients: A Review</title><source>SpringerLink Journals - AutoHoldings</source><creator>Sigler, Rachel ; Aslam, Saima</creator><creatorcontrib>Sigler, Rachel ; Aslam, Saima</creatorcontrib><description>Purpose of Review This review summarizes the literature on invasive candidiasis (IC) in liver transplant recipients (LTRs) regarding diagnostic strategies, treatment, and prophylaxis. Recent Findings Recent literature on IC has expanded and refined definitions of risk factors for IC in LTRs. We discuss increasing rates of resistance among candida species and new antifungals. Diagnostic modalities continue to decrease time to initiation of empiric antifungals, which may impact outcomes. Summary A well-documented host of risk factors for IC may allow for targeted prophylaxis, while minimizing exposure to antifungal medications. Further research on minimum effective duration of treatment and prophylaxis is needed to combat resistance.</description><identifier>ISSN: 1936-3761</identifier><identifier>EISSN: 1936-377X</identifier><identifier>DOI: 10.1007/s12281-021-00426-6</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Candidiasis ; Disease prevention ; Fungal Infections in Transplantation (S Shoham ; Infectious Diseases ; Internal Medicine ; Liver transplantation ; Liver transplants ; Medicine ; Medicine &amp; Public Health ; Occupational Medicine/Industrial Medicine ; Pneumology/Respiratory System ; Prophylaxis ; Reviews ; Risk factors ; Section Editor ; Topical Collection on Fungal Infections in Transplantation ; Tropical Medicine</subject><ispartof>Current fungal infection reports, 2021-12, Vol.15 (4), p.151-161</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021</rights><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c270t-65d7b965de7719c2ef9e6b9c16e6404f35c77af2ee1971a601e71448b455a1923</cites><orcidid>0000-0002-8861-1150</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12281-021-00426-6$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12281-021-00426-6$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,777,781,27905,27906,41469,42538,51300</link.rule.ids></links><search><creatorcontrib>Sigler, Rachel</creatorcontrib><creatorcontrib>Aslam, Saima</creatorcontrib><title>Invasive Candidiasis in Liver Transplant Recipients: A Review</title><title>Current fungal infection reports</title><addtitle>Curr Fungal Infect Rep</addtitle><description>Purpose of Review This review summarizes the literature on invasive candidiasis (IC) in liver transplant recipients (LTRs) regarding diagnostic strategies, treatment, and prophylaxis. Recent Findings Recent literature on IC has expanded and refined definitions of risk factors for IC in LTRs. We discuss increasing rates of resistance among candida species and new antifungals. Diagnostic modalities continue to decrease time to initiation of empiric antifungals, which may impact outcomes. Summary A well-documented host of risk factors for IC may allow for targeted prophylaxis, while minimizing exposure to antifungal medications. Further research on minimum effective duration of treatment and prophylaxis is needed to combat resistance.</description><subject>Candidiasis</subject><subject>Disease prevention</subject><subject>Fungal Infections in Transplantation (S Shoham</subject><subject>Infectious Diseases</subject><subject>Internal Medicine</subject><subject>Liver transplantation</subject><subject>Liver transplants</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Occupational Medicine/Industrial Medicine</subject><subject>Pneumology/Respiratory System</subject><subject>Prophylaxis</subject><subject>Reviews</subject><subject>Risk factors</subject><subject>Section Editor</subject><subject>Topical Collection on Fungal Infections in Transplantation</subject><subject>Tropical Medicine</subject><issn>1936-3761</issn><issn>1936-377X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9UE1LAzEUDKJgrf4BTwueV_Py2QgeSrFaKAhSwVvI7r6VlJquybbivze6ojcP72MeM_NgCDkHegmU6qsEjE2gpCwXFUyV6oCMwHBVcq2fD393BcfkJKU1pQq04SNyswh7l_wei5kLjW98BqnwoVjmWyxW0YXUbVzoi0esfecx9Om6mGa09_h-So5at0l49jPH5Gl-u5rdl8uHu8VsuixrpmlfKtnoyuSOWoOpGbYGVWVqUKgEFS2XtdauZYhgNDhFATUIMamElA4M42NyMfh2cfu2w9Tb9XYXQ35pmaJiIrlUMrPYwKrjNqWIre2if3XxwwK1XzHZISabY7LfMVmVRXwQpUwOLxj_rP9RfQLCmmkC</recordid><startdate>20211201</startdate><enddate>20211201</enddate><creator>Sigler, Rachel</creator><creator>Aslam, Saima</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0002-8861-1150</orcidid></search><sort><creationdate>20211201</creationdate><title>Invasive Candidiasis in Liver Transplant Recipients: A Review</title><author>Sigler, Rachel ; Aslam, Saima</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c270t-65d7b965de7719c2ef9e6b9c16e6404f35c77af2ee1971a601e71448b455a1923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Candidiasis</topic><topic>Disease prevention</topic><topic>Fungal Infections in Transplantation (S Shoham</topic><topic>Infectious Diseases</topic><topic>Internal Medicine</topic><topic>Liver transplantation</topic><topic>Liver transplants</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Occupational Medicine/Industrial Medicine</topic><topic>Pneumology/Respiratory System</topic><topic>Prophylaxis</topic><topic>Reviews</topic><topic>Risk factors</topic><topic>Section Editor</topic><topic>Topical Collection on Fungal Infections in Transplantation</topic><topic>Tropical Medicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sigler, Rachel</creatorcontrib><creatorcontrib>Aslam, Saima</creatorcontrib><collection>CrossRef</collection><jtitle>Current fungal infection reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sigler, Rachel</au><au>Aslam, Saima</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Invasive Candidiasis in Liver Transplant Recipients: A Review</atitle><jtitle>Current fungal infection reports</jtitle><stitle>Curr Fungal Infect Rep</stitle><date>2021-12-01</date><risdate>2021</risdate><volume>15</volume><issue>4</issue><spage>151</spage><epage>161</epage><pages>151-161</pages><issn>1936-3761</issn><eissn>1936-377X</eissn><abstract>Purpose of Review This review summarizes the literature on invasive candidiasis (IC) in liver transplant recipients (LTRs) regarding diagnostic strategies, treatment, and prophylaxis. Recent Findings Recent literature on IC has expanded and refined definitions of risk factors for IC in LTRs. We discuss increasing rates of resistance among candida species and new antifungals. Diagnostic modalities continue to decrease time to initiation of empiric antifungals, which may impact outcomes. Summary A well-documented host of risk factors for IC may allow for targeted prophylaxis, while minimizing exposure to antifungal medications. Further research on minimum effective duration of treatment and prophylaxis is needed to combat resistance.</abstract><cop>New York</cop><pub>Springer US</pub><doi>10.1007/s12281-021-00426-6</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-8861-1150</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1936-3761
ispartof Current fungal infection reports, 2021-12, Vol.15 (4), p.151-161
issn 1936-3761
1936-377X
language eng
recordid cdi_proquest_journals_2604853565
source SpringerLink Journals - AutoHoldings
subjects Candidiasis
Disease prevention
Fungal Infections in Transplantation (S Shoham
Infectious Diseases
Internal Medicine
Liver transplantation
Liver transplants
Medicine
Medicine & Public Health
Occupational Medicine/Industrial Medicine
Pneumology/Respiratory System
Prophylaxis
Reviews
Risk factors
Section Editor
Topical Collection on Fungal Infections in Transplantation
Tropical Medicine
title Invasive Candidiasis in Liver Transplant Recipients: A Review
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T18%3A10%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Invasive%20Candidiasis%20in%20Liver%20Transplant%20Recipients:%20A%20Review&rft.jtitle=Current%20fungal%20infection%20reports&rft.au=Sigler,%20Rachel&rft.date=2021-12-01&rft.volume=15&rft.issue=4&rft.spage=151&rft.epage=161&rft.pages=151-161&rft.issn=1936-3761&rft.eissn=1936-377X&rft_id=info:doi/10.1007/s12281-021-00426-6&rft_dat=%3Cproquest_cross%3E2604853565%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2604853565&rft_id=info:pmid/&rfr_iscdi=true